Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Major pharmacy chains are planning to shutter hundreds of stores in 2025, making access to medications more difficult.

The U.S. Department of Justice this week filed a lawsuit against Walgreens, alleging the company knowingly filled illegal ...

RBC Capital analyst Ben Hendrix raised the firm’s price target on Walgreens Boots Alliance (WBA) to $12 from $9 and keeps a Sector Perform ...

“However, we think it is premature to say that Walgreens is on a stable path to growth,” he said, noting that prescription reimbursement changes will take time and their impact remains uncertain. In ...

Retail pharmacy chain Walgreens Boots Alliance (WBA) is scheduled to announce its results for the first quarter of Fiscal 2025 on January 10. WBA stock plunged by more than 60% last year ...

The Health System Owned Specialty Pharmacy Alliance (HOSP) is pleased to announce the appointment of Tim Affeldt, PharmD, Vice President, Specialty/Infusion Operations, Fairview Pharmacy Services ...

The latest earnings from Walgreens Boots Alliance will also be in focus, following recent reports of talks around a potential private equity buyout deal. In the UK, high street stalwart Marks & ...

Walgreens Boots Alliance (WBA) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended November 2024.

Walgreens Boots Alliance (WBA) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended November 2024. This widely-known ...

Walgreens Boots Alliance (Nasdaq: WBA) is an integrated healthcare, pharmacy and retail leader serving millions of customers and patients every day, with a 175-year heritage of caring for communities.